Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A case study of the effectiveness an after-hours telemedicine service at a skilled nursing facility (SNF) showed the facility hospitalizations decrease by 18 percent while saving more than $1.5 million in Medicare costs.
On the heels of a new $350 million investment from private equity group The Carlyle Group, One Medical is setting its sights even higher—aiming to reduce healthcare spending by 10 percent, CNBC reported.
The Duke Clinical Research Institute in Durham, North Carolina, and Cerner partnered to develop a cardiac risk app that shares patient information with physicians about risk factors associated with heart disease and stroke.
The family of deceased rock star Prince is suing a doctor they said prescribed pain pills, claiming the physician did not treat him for opiate addiction and bears some responsibility for his April 2016 death.
Gene therapy company bluebird bio and cancer immunotherapy company Gritstone Oncology are working together to research, develop and produce a cancer treatment product that will use cell therapy.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.